Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.085
-0.035 (-1.65%)
Sep 11, 2024, 3:01 PM EDT - Market open
Cellectar Biosciences Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$20.00
Upside
+859.23%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $20 → $28 | Strong Buy | Maintains | $20 → $28 | +1,242.93% | Mar 28, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $11 → $12 | Buy | Reiterates | $11 → $12 | +475.54% | Mar 28, 2024 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +859.23% | Mar 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 → $4 | Strong Buy | Maintains | $3 → $4 | +91.85% | Nov 4, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $55 | Buy | Initiates | $55 | +2,537.89% | Jul 18, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jul 1, 2020 |
| Maxim Group | Maxim Group | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jun 23, 2020 |
| Roth Capital | Roth Capital | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jan 21, 2020 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Dec 21, 2016 |